AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Earnings call: Artivion Posts Strong Growth, Expands Global Presence
Feb 16, 2024 10:53am

https://www.investing.com/news/stock-market-news/earnings-call-artivion-posts-strong-growth-expands-global-presence-93CH-3305964


Source:Investing.com
Artivion Non-GAAP EPS of $0.11, revenue of $93.7M beats by $4.41M
Feb 15, 2024 21:17pm

No summary available.


Source:Seeking Alpha
Artivion Inc at Deutsche Bank Leveraged Finance Conference Transcript
Feb 09, 2024 23:19pm

Artivion Inc at Deutsche Bank Leveraged Finance Conference Transcript


Source:GuruFocus
Artivion Inc Investor Update Call Transcript
Feb 09, 2024 23:19pm

Artivion Inc Investor Update Call Transcript


Source:GuruFocus
Artivion Inc at UBS Global Healthcare Conference Transcript
Feb 09, 2024 23:19pm

Artivion Inc at UBS Global Healthcare Conference Transcript


Source:GuruFocus
Artivion Inc at Needham Healthcare Conference (Virtual) Transcript
Feb 09, 2024 23:19pm

Artivion Inc at Needham Healthcare Conference (Virtual) Transcript


Source:GuruFocus
Artivion Inc Investor & Analyst Day Transcript
Feb 09, 2024 23:19pm

Artivion Inc Investor & Analyst Day Transcript


Source:GuruFocus
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
Feb 01, 2024 21:10pm

ATLANTA, Feb. 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2023 financial results will be released on Thursday, February 15, 2024 after the market closes. On…


Source:PR Newswire
Artivion Obtains $350 Million in Senior Secured Credit Facilities
Jan 18, 2024 21:05pm

Non-Dilutive Financing Provides Comprehensive Solution to Address Debt Maturities and Provide Flexibility to Further Optimize Capital Structure ATLANTA, Jan. 18, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease,…


Source:PR Newswire
Artivion Obtains $350 Million in Senior Secured Credit Facilities | AORT Stock News
Jan 18, 2024 21:05pm

Artivion, Inc. (NYSE: AORT) has closed a $350 million non-dilutive credit agreement with Ares Management Credit funds, consisting of senior secured, interest-only credit facilities with 6-year maturities. The agreement includes an initial $190 million term loan, a $60 million revolving credit facility, and an additional $100 million in unfunded delayed draw term loan commitments. The company plans to use the funds to address debt maturities and optimize its capital structure. The agreement reflects the company''s confidence in its business outlook and aims to deliver significant shareholder value.


Source:Stock Titan